Covington Associates Advises Century Specialty Script in its sale to Superior Biologics
BOSTON, MA – January 2, 2017 – Covington Associates LLC, a leading middle market investment bank, announced its role as exclusive advisor to Century Specialty Script (“Century”), a leading provider of specialty pharmacy services, in its sale to Superior Biologics, (“Superior”), a leading national provider of high-touch infusion and specialty pharmacy services. Headquartered in White Plains, New York, Century Specialty Script ( “CSS” or “the Company”) offers physicians and patients an efficient and effective way of managing complex, chronic diseases is one of the fastest growing, independent specialty pharmacies serving patients throughout the state of New York, with a particular focus on the New York City, Long Island (NY), Westchester County (NY), and New Jersey marketplaces. The Company offers individualized, pharmaceutical care for a variety of challenging health conditions and complex drug therapies such as: Hepatitis C, Rheumatoid Arthritis, Oncology, IVIG, Hemophilia, and other chronic diseases. Tom Cibotti, Managing Director of Covington Associates said “We are pleased to have been given the opportunity to represent such a high quality, well-regarded specialty pharmacy as Century Script. Century Scripts’ commitment to patient care and targeted therapy management programs make it a great platform as Superior Biologics looks to expand its specialty infusion business”. About Covington Associates Covington Associates is an investment banking firm offering advisory services in the areas of mergers and acquisitions (“M&A”), capital raising, strategic advisory, fairness opinions, and valuations to middle-market companies across the Healthcare, Business Services, Consumer & Industrial, and Technology verticals. Founded in 1991, with offices in Boston, and New York, the vision for Covington has been to provide clients with the highest caliber of senior-level attention and to remain an advice driven and results focused organization. Since its inception, Covington Associates has completed more than 200 transactions globally for both private and publicly traded companies totaling over $15 billion. About Century Specialty Script Founded in 2005, Century Specialty Script is a leading, independent specialty pharmacy serving patients throughout the state of New York, with a particular focus on the New York City, Long Island (NY), Westchester County (NY), and New Jersey marketplaces. The Company offers individualized, pharmaceutical care for a variety of challenging health conditions and complex drug therapies such as: Hepatitis C, Rheumatoid Arthritis, Oncology, IVIG, Hemophilia, and other chronic diseases. About Superior Biologics Superior Biologics is a leading home infusion and specialty provider offering services to pediatric and adult populations suffering from both acute and chronic illnesses. The Company’s goal is to provide cost-effective and highly compassionate care to its patients, which ultimately leads to healthy therapeutic outcomes and enhanced quality of life. Superiors’ dedicated team of clinicians are able to serve a wide variety of disease states, including, but not limited to Immune Globulin Therapy (IVIG & SCIG), HCV Therapies, Hemophilia & Bleeding disorders, and other rare and chronic conditions.
Farm was acquired by Flextronics
Farm was acquired by Flextronics, a leading global electronics manufacturing services company with an emphasis on medical devices, drug delivery systems, diagnostics and capital equipment. Press Release >>
Emory Univesity has entered into a joint venture for its Emory Genetics Laboratory with Eurofins
Covington advised Emory University on the sale of 75% of its Emory Genetics Lab to Eurofins for $41.3m in cash and a 25% stake in the newco EGL Genetics Diagnostics, LLC. Press Release>>
Pharmalucence acquired by Sun Pharmaceuticals
Covington Associates, LLC acted as financial advisor to Pharmalucence, Inc., a Massachusetts based manufacturer of sterile injectable pharmaceuticals, in its sale to Sun Pharmaceutical Industries Ltd., an India based specialty pharmaceutical company. >Press Release
Hobart Group Holdings acquired by Precision For Medicine
Covington Associates advised Hobart Group Holdings, a leading market access firm, on their acquisition by Precision For Medicine, a specialized services company supporting next generation approaches to drug development and commercialization. >Press Release
Applied Computational Technologies acquired by Varian Medical Systems
Applied Computational Technologies, LLC (ACT), a PA based developer of software for life sciences application in radiation treatment planning for cancer therapy, completed the sale of certain intellectual property assets to Varian Medical Systems (VAR – NYSE), a leading manufacturer of medical devices and software for treating cancer and other medical conditions. Covington Associates acted as financial advisor to ACT.
Premier Source acquired by AmerisourceBergen
Covington Associates acted as exclusive financial advisor to Premier Source, a privately held company that provides consulting and reimbursement services to medical device, pharmaceutical, molecular diagnostic, and biotechnology manufacturers, as well as other health services companies, in its sale to AmerisourceBergen Corporation (NYSE:ABC). >Press Release
InfoMedics acquired by Physicians Interactive
Covington Associates announced it acted as exclusive financial advisor to InfoMedics, the industry expert in the design and delivery of interactive patient communications platforms, in its sale to Physicians Interactive. >Press Release
BioSeek acquired by DiscoveRx
Covington Associates announced it acted as exclusive financial advisor to BioSeek, plc, a provider of high quality, human-tissue based tools and services for drug and drug target discovery, in its sale to DiscoveRx Corporation. >Press Release
Asterand acquired by Stemgent
Asterand, the leading global provider of high quality, well characterized human tissue and human tissue-based research solutions to drug discovery scientists, was acquired by Stemgent. >Press Release
Covington Associates advises Fluxion Biosciences on $12 Million Capital Raise
Covington Associates announced it acted as exclusive financial advisor to Fluxion Biosciences on its $12 million Series C capital raise led by Signet Healthcare Partners. Existing investors Claremont Creek Ventures and Kodiak Venture Partners also participated in the round. Fluxion Biosciences is a developer and manufacturer of systems and microfluidic consumables for running functional cell-based assays.
Med-Vantage, Inc. acquired by IMS Health
Covington Associates acted as exclusive financial advisor to Med-Vantage, Inc., a software solutions company, in its sale to IMS, a global provider of information services for the healthcare industry. >Press Release
Inverness Medical Innovations nutritionals business acquired by International Vitamin Corporation
Covington Associates announced it acted as financial advisor to Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, in the sale of its nutritionals business to International Vitamin Corporation and affiliates. >Press Release
Tourtellotte Solutions acquired by BioClinica, Inc.
Covington Associates acted as financial advisor to Tourtellotte Solutions, a software and services firm focused on providing cutting edge products, custom application development and consulting services, in its sale to BioClinica, Inc. (NASDAQ: BIOC).
Pharsight Corporation acquired by Tripos International
Covington Associates announced today it acted as financial advisor to Pharsight Corporation (NASDAQ: PHST), a leading provider of software, strategic, and regulatory services designed to optimize clinical drug development, in its sale to Tripos International, a portfolio company of Vector Capital.
Eidetics acquired by Quintiles Transnational
Covington Associates acted as financial advisor to Eidetics, a privately held data analytics and market research consulting company, in its sale to Quintiles Transnational Corp. >Press Release
Galt acquired by Cerner Corporation
Covington Associates LLC has advised Galt Associates, Inc., a leading provider of safety and risk management solutions for pharmaceutical, medical device and biotechnology companies, in its sale to Cerner Corporation (NASDAQ: CERN), a leading supplier of healthcare information technology. The terms of the transaction were not disclosed. >Press Release
Metaworks acquired by United BioSource
Covington Associates LLC has advised to Metaworks, Inc., a leading provider of systematic reviews and meta-analyses to inform development, marketing, and regulatory decision-making regarding health care products and services, in its sale to United BioSource Corporation, a provider of evidence-based services to enhance the medical and commercial potential of pharmaceuticals, biotechnology, medical devices and diagnostics.